Mass General Brigham-Brigham and Women's Hospital-Massachusetts General Hospital-Harvard Medical School Program

Program Identity & Fit

The Harvard Radiation Oncology Program is the merged, quaternary academic training program spanning MGH, Brigham and Women's, Dana-Farber, and Boston Children's Hospital, representing the largest radiation oncology residency in the country and explicitly positioned to train future chairs and program directors of the field. Clinical training rotates residents through single-institution, single-attending disease-site blocks across the full range of modalities, including proton therapy, MR Linac, brachytherapy, and robotic radiosurgery, reflecting a tertiary/quaternary complex-case environment. Research is structurally central: a dedicated PGY-4 research year, mentored basic/translational/clinical projects beginning in PGY-2/3, and an established Holman Research Pathway for residents pursuing extended physician-scientist training. The program's stated mission and alumni trajectory (numerous chairs, program directors, and MD/PhD physician-scientists) demonstrate that it selects for and cultivates future academic leadership rather than community clinical practice.